norgestrel has been researched along with Breast Neoplasms in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (50.00) | 18.7374 |
| 1990's | 9 (30.00) | 18.2507 |
| 2000's | 4 (13.33) | 29.6817 |
| 2010's | 1 (3.33) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Burchardt, NA; Eliassen, AH; Fortner, RT; Kaaks, R; Rosner, B; Shafrir, AL; Tamimi, RM; Tworoger, SS | 1 |
| Bartrons, R; Jordan, A; Manzano, A; Millán-Ariño, L; Navarro-Sabate, A; Novellasdemunt, L; Obach, M; Rosa, JL; Ventura, F | 1 |
| Caubel, P; Chetrite, GS; Friedman, AJ; Pasqualini, JR; Philippe, JC | 1 |
| Evtimova, V; Kaul, S; Weidle, UH; Zeillinger, R | 1 |
| Boerstoel-Streefland, M; Hendricks, PT; Wierik, EJ | 1 |
| Lelle, I; Prifti, S; Rabe, T; Strowitzki, T | 1 |
| Bayard, F; Jozan, S; Kreitmann, B | 1 |
| Boccardo, E; Larosa, E; Ragni, N; Viglino, S | 1 |
| Wingrave, SJ | 1 |
| Boccardo, E; De Cecco, L; Ragni, N; Viglino, S | 1 |
| Durand, JC; Fournier, S; Kuttenn, F; Mauvais-Jarvis, P | 1 |
| Sobel, NB | 1 |
| Catherino, WH; Jeng, MH; Jordan, VC | 1 |
| Diamandis, EP; Grass, L; Zarghami, N | 1 |
| Hyder, SM; Murthy, L; Stancel, GM | 1 |
| Ballinger, JR; Diamandis, EP; Kogan, I; Kuba, RM; Melegos, DN; Rauth, AM; Redshaw, R | 1 |
| Diamandis, EP; Jenkins, DJ; Rosenberg Zand, RS | 1 |
| Bohnet, HG; del Pozo, E; Naber, NG; Schneider, HP | 1 |
| Degueldre, M; Delvoye, P; Hubinont, PO; L'Hermite, M; Robyn, C; Vekemans, M | 1 |
| Heil, CG; Korba, VD | 1 |
| Jeng, MH; Jordan, VC; Parker, CJ | 1 |
| Back, DJ; Rudland, PS; Wild, MJ | 1 |
| Bayard, F; Dupont, MA; Gas, N; Jozan, S; Roubinet, F; Valette, A | 1 |
| Bayard, F; David, JF; Faye, JC; Jozan, S; Tauber, JP; Tournier, JF | 1 |
| Hammerstein, J | 1 |
| Avery, GS; Brogden, RN; Speight, TM | 1 |
| Hoffmann, G; Oertel, GW; Rindt, W; Schirazi, M; Strubel, HB | 1 |
2 review(s) available for norgestrel and Breast Neoplasms
| Article | Year |
|---|---|
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship | 1994 |
Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone.
Topics: Breast Neoplasms; Chlormadinone Acetate; Contraceptives, Oral; Corpus Luteum; Dose-Response Relationship, Drug; Female; Fertility; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Mucus; Norethindrone; Norgestrel; Pregnancy; Thromboembolism; Vaginal Neoplasms | 1973 |
1 trial(s) available for norgestrel and Breast Neoplasms
| Article | Year |
|---|---|
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners.
Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Lipoproteins; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Thrombosis | 1982 |
27 other study(ies) available for norgestrel and Breast Neoplasms
| Article | Year |
|---|---|
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Topics: Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Nurses; Progestins; Prospective Studies | 2022 |
Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells.
Topics: Base Sequence; Breast Neoplasms; Cell Line, Tumor; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Norgestrel; Phosphofructokinase-2; Pregnenediones; Progesterone Congeners; Promoter Regions, Genetic; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm | 2012 |
Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethisterone; Humans; Inhibitory Concentration 50; Medroxyprogesterone Acetate; Models, Chemical; Norgestrel; Oximes; Selective Estrogen Receptor Modulators; Sulfatases; Tumor Cells, Cultured | 2003 |
Identification of CRASH, a gene deregulated in gynecological tumors.
Topics: Amino Acid Sequence; Asparaginase; Autoantigens; Base Sequence; Blotting, Northern; Breast Neoplasms; Cell Line, Tumor; Cloning, Molecular; Dihydrotestosterone; DNA, Complementary; Estradiol; Exons; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes; Genital Neoplasms, Female; HeLa Cells; HL-60 Cells; Humans; Immunohistochemistry; Introns; K562 Cells; Molecular Sequence Data; Norgestrel; RNA, Messenger; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2004 |
Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study.
Topics: Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Norpregnenes; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; United Kingdom | 2004 |
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured | 2004 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture.
Topics: Breast Neoplasms; Cell Division; Cell Line; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Levonorgestrel; Norgestrel; Progesterone; Receptors, Progesterone; Tamoxifen | 1981 |
Oral contraception and breast pathology.
Topics: Adenofibroma; Adenoma; Adult; Animals; Breast Feeding; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estradiol Congeners; Female; Fibrocystic Breast Disease; Humans; Levonorgestrel; Menarche; Middle Aged; Norgestrel; Parity; Pregnancy; Progesterone Congeners; Retrospective Studies; Stereoisomerism | 1981 |
[Effects of hormonal contraception on benign changes of the breast].
Topics: Adenofibroma; Adenoma; Adult; Breast Diseases; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cysts; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel | 1982 |
Estradiol and progesterone receptors in human breast fibroadenomas.
Topics: Adenofibroma; Adolescent; Adult; Breast Neoplasms; Cell Nucleus; Contraceptives, Oral, Combined; Cytosol; Ethinyl Estradiol; Female; Humans; Lynestrenol; Menstruation; Norgestrel; Receptors, Estradiol; Receptors, Estrogen; Receptors, Progesterone | 1981 |
Estrogen replacement therapy in women with previously treated breast cancer. ACOG Committee Opinion: Committee on Gynecologic Practice Number 135-April 1994.
Topics: Adult; Breast Neoplasms; Case-Control Studies; Delayed-Action Preparations; DNA, Neoplasm; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Norgestrel; Postmenopause; Risk Factors; RNA, Neoplasm; Tamoxifen | 1994 |
Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism.
Topics: Base Sequence; Breast Neoplasms; Cell Division; Estradiol; Estrogens; Female; Gene Expression; Humans; In Vitro Techniques; Mifepristone; Molecular Sequence Data; Norgestrel; Norpregnenes; Polyunsaturated Alkamides; Promoter Regions, Genetic; Receptors, Estrogen; Regulatory Sequences, Nucleic Acid; Transcription, Genetic; Tumor Cells, Cultured | 1993 |
Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.
Topics: Androgens; Base Sequence; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Norgestrel; Polymerase Chain Reaction; Progestins; Prostate-Specific Antigen; RNA, Messenger; Tumor Cells, Cultured | 1997 |
Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Prostate-specific antigen induction by a steroid hormone in T47D cells growing in SCID mice.
Topics: Animals; Breast Neoplasms; Female; Humans; Immunohistochemistry; Male; Mammary Glands, Animal; Mice; Mice, SCID; Norgestrel; Progesterone Congeners; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured | 1998 |
Development and evaluation of a competitive time-resolved immunofluorometric assay for the estrogen-regulated protein pS2.
Topics: Aldosterone; Amino Acid Sequence; Antibodies, Monoclonal; Binding, Competitive; Biotin; Breast Neoplasms; Calibration; Chemistry, Clinical; Dexamethasone; Dihydrotestosterone; Dose-Response Relationship, Immunologic; Drosophila Proteins; Estradiol; Evaluation Studies as Topic; Fluorescent Antibody Technique; Fluorometry; Glucocorticoids; Integrin alpha Chains; Integrins; Molecular Sequence Data; Nandrolone; Norgestrel; Progesterone Congeners; Sensitivity and Specificity; Testosterone Congeners; Tumor Cells, Cultured | 1999 |
Effects of synthetic gestagens on serum prolactin and growth hormone secretion in amenorrheic patients.
Topics: Amenorrhea; Breast Neoplasms; Female; Growth Hormone; Humans; Medroxyprogesterone; Metoclopramide; Norethindrone; Norgestrel; Prolactin; Radioimmunoassay | 1978 |
[Clinical pharmacology of hormonal contraceptives].
Topics: Adult; Aged; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Medroxyprogesterone; Middle Aged; Norethindrone; Norgestrel; Prolactin | 1975 |
Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
Topics: Adrenal Glands; Adult; Breast Neoplasms; Cervix Uteri; Contraception; Drug Evaluation; Ethinyl Estradiol; Eye; Female; Fertility; Follow-Up Studies; Humans; Infant, Newborn; Liver; Maternal-Fetal Exchange; Menstruation; Menstruation Disturbances; Norgestrel; Pregnancy; Thromboembolism; Thyroid Gland | 1975 |
Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Topics: Amino Acid Sequence; Breast Neoplasms; Cell Division; Chloramphenicol O-Acetyltransferase; Dose-Response Relationship, Drug; Enzyme Induction; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Molecular Sequence Data; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Protein-Tyrosine Kinases; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1992 |
Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR-75-1) human breast cells in culture.
Topics: Breast; Breast Neoplasms; Cell Line; Contraceptives, Oral; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Norgestrel; Radioisotope Dilution Technique; Tritium; Tumor Cells, Cultured | 1991 |
Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Cell Line; Estradiol; Female; Humans; Interphase; Levonorgestrel; Norgestrel; Tamoxifen; Tetradecanoylphorbol Acetate | 1987 |
Oral contraception, 1986. Endocrinology and pharmacology. A panel discussion.
Topics: Adult; Animals; Breast Neoplasms; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Mestranol; Middle Aged; Norethindrone; Norgestrel; Rats; Risk | 1986 |
Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions.
Topics: Breast Neoplasms; Cell Count; Cell Division; Cell Line; Culture Media; Drug Interactions; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Tamoxifen; Thymidine; Tritium | 1985 |
[Principles of hormonal contraception].
Topics: Acne Vulgaris; Adult; Alopecia; Animals; Breast Neoplasms; Chlormadinone Acetate; Contraception; Contraceptives, Oral; Contraceptives, Postcoital; Cyproterone; Delayed-Action Preparations; Dermatitis, Seborrheic; Dogs; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Injections, Intramuscular; Norgestrel; Progestins | 1972 |
Cytostatic effects of G-6-PDH inhibitors in cell cultures from normal and neoplastic tissue.
Topics: Breast Neoplasms; Cells, Cultured; Dehydroepiandrosterone; DNA; Female; Glucosephosphate Dehydrogenase; Humans; Neoplasms; Norgestrel; Ovarian Neoplasms; Progesterone; Thymidine; Tritium | 1974 |